GSK Says Efficacy Of Its Shingles Vaccine Remains High After Years GSK Says Efficacy Of Its Shingles Vaccine Remains High After Years

British drugmaker GSK said on Wednesday long-term data showed that its blockbuster shingles vaccine, Shingrix, had 79.7% efficacy in participants aged 50 years and above,...Reuters Health Information
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news